Close Menu

NEW YORK (GenomeWeb) – PerkinElmer announced after the close of the market on Thursday that its fourth quarter revenues rose 18 percent year over year.

For the three months ended Dec. 30, 2018, the company posted revenues of $756.3 million compared to $641.6 million a year ago. It beat the consensus Wall Street estimate of $746.6 million.

Core organic revenue growth was 7 percent, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.